Digital Pharmaceuticals: A Hypothesis for Information-Based Therapeutics

The concept of "digital pharmaceuticals" has emerged from the broader hypothesis that

biological systems may respond not only to chemical molecules but also to information encoded in electromagnetic signals. While digital representations of homeopathic preparations and other information-based therapeutic approaches have been proposed by several researchers, the scientific validity and clinical efficacy of these methods remain controversial and require rigorous experimental verification.

This paper reviews historical concepts related to biological electromagnetic communication, including early ideas proposed by Albert Szent-Györgyi, investigations into water memory by Jacques Benveniste, and later electromagnetic signal studies reported by Luc Montagnier.

It discusses theoretical models suggesting that biological interactions may involve resonance.

Based on these concepts, a hypothetical framework is proposed in which the electromagnetic signature of biologically active compounds could be recorded, digitized, stored, and retransmitted through suitable physical media. Potential applications—including information- based therapeutics, laboratory diagnostics, and agricultural technologies—are discussed as speculative research directions rather than established clinical methods.

Finally, an experimental protocol is suggested to allow objective testing of these hypotheses under blinded, reproducible laboratory conditions. The paper emphasizes that these concepts remain experimental and should not be considered substitutes for evidence-based pharmaceutical therapies until validated by rigorous scientific investigation.